Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

The direct way from MRI to radiation treatment

No. 66a | 18/12/2014

For the first time this year, the Roland Ernst Foundation for Medical Research awards a €5000 prize for interdisciplinary radiological research. The award will be presented to scientists from the Research Program “Imaging and Radiooncology“ of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) for an excellent cross-departmental project.

from left: Heinz-Peter Schlemmer, Florian Sterzing, Roland Ernst, Asja Pfaffenberger and Tilmann Bostel
© Tobias Schwerdt/DKFZ

This year‘s award winners are Dr. Tilmann Bostel and Asscociate Professor (PD) Dr. Florian Sterzing from the Clinical Cooperation Unit Radiation Oncology and Dr. Asja Pfaffenberger from the Division of Medical Physics in Radiation Therapy. They will receive the award in recognition of their cross-disciplinary project on MR-guided radiotherapy planning.

In a cross-disciplinary collaboration, the two physicians Bostel and Sterzing and physicist Asja Pfaffenberger have developed a positioning system that makes it possible to transfer patients directly from an MRI device to a linear accelerator (LINAC) where they receive radiation treatment.

MRI (magnetic resonance imaging) is considered an ideal imaging technology to plan radiation therapy, to verify a patient’s position immediately before radiation treatment, or to document the course of radiation therapy. MRI attains much better soft tissue contrast than commonly used computer tomography (CT) and additionally does not involve radiation exposure.

To date, experimental hybrid devices that combine LINAC and MRI exist only in two places in the world. However, they are not being used yet to treat patients. The shuttle system developed by the three award-winning scientists will now make it possible to transfer patients directly from an MRI device to a neighboring radiotherapy unit without repositioning. The system guarantees that the patient's position remains exactly identical throughout imaging and irradiation. This makes it possible to localize tumors and healthy tissue very precisely over the whole treatment period in order to adjust radiation therapy individually if the tumor has shifted since the last treatment or if its size has changed.

“Close collaboration across various disciplines has always been a characteristic of our Research Program,” says coordinator Prof. Heinz-Peter Schlemmer. “Radiologists, nuclear medicine specialists, radiation therapists, medical physicists, chemists and computer scientists are all collaborating closely here to address medically relevant issues. And thanks to our excellent precision engineers, we can even produce our own prototype devices if needed.”

This cross-disciplinary collaboration is also the prerequisite for the Roland Ernst Prize, whose statutes require a cross-departmental project that should also have the potential for translation into clinical applications.

Established in 1980 by Heidelberg construction entrepreneur Roland Ernst, the Roland Ernst Foundation supports medical research, particularly the DKFZ Research Program “Radiological Diagnostics and Therapy” (now: Imaging and Radiooncology). In addition, the foundation also sponsors art and culture projects.

With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.

To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:

  • National Center for Tumor Diseases (NCT, 6 sites)
  • German Cancer Consortium (DKTK, 8 sites)
  • Hopp Children's Cancer Center (KiTZ) Heidelberg
  • Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
  • DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
  • National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.


Subscribe to our RSS-Feed.

to top
powered by webEdition CMS